e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Function of PTEN/PI3k/AKT pathway in bronchioalveolar epithelium in the pathogenesis of lung fibrosis
H. Tsubouchi, K. Miyoshi, S. Yanagi, Y. Imazu, Y. Arimura, N. Matsumoto, J. I. Ashitani, K. Kawahara, A. Suzuki, M. Nakazato (Miyazaki, Fukuoka, Japan)
Source:
Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Session:
From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Session type:
Oral Presentation
Number:
4460
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Tsubouchi, K. Miyoshi, S. Yanagi, Y. Imazu, Y. Arimura, N. Matsumoto, J. I. Ashitani, K. Kawahara, A. Suzuki, M. Nakazato (Miyazaki, Fukuoka, Japan). Function of PTEN/PI3k/AKT pathway in bronchioalveolar epithelium in the pathogenesis of lung fibrosis. Eur Respir J 2009; 34: Suppl. 53, 4460
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Investigation of the status of cystic fibrosis airway epithelial cells
Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy
Year: 2008
Apoptosis in lung injury and fibrosis
Source: Eur Respir J 2008; 32: 1631-1638
Year: 2008
MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004
Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Do characteristic airway epithelial change precede the development of lung fibrosis? Ectopic epithelial marker protein expression in bleomycin induced fibrosis replicates that seen in bronchiolized epithelium in IPF
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Pathogenetic pathways in pulmonary fibrosis: The role of bronchoalveolar lavage (BAL) cellularity in relation to epithelial injury
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
microRNA-mediated inhibition of IL-8 production from cystic fibrosis bronchial epithelial cells
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept